Claritev (NYSE:CTEV) Price Target Raised to $30.00

Claritev (NYSE:CTEV) had its price target hoisted by stock analysts at Wells Fargo & Company from $22.00 to $30.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target indicates a potential downside of 14.31% from the company’s current price.

A number of other research firms also recently issued reports on CTEV. Barclays started coverage on Claritev in a research note on Friday, April 24th. They issued an “overweight” rating and a $28.00 price target on the stock. Zacks Research downgraded Claritev from a “hold” rating to a “strong sell” rating in a research report on Friday, July 17th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Claritev in a research note on Wednesday, June 24th. Piper Sandler set a $61.00 price target on shares of Claritev in a report on Wednesday, June 3rd. Finally, Citigroup reiterated a “buy” rating and issued a $45.00 price target (up from $40.00) on shares of Claritev in a research note on Monday. Five analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $40.83.

Claritev Trading Up 2.8%

Claritev stock opened at $35.01 on Wednesday. The business’s fifty day simple moving average is $29.15 and its two-hundred day simple moving average is $23.83. Claritev has a 12 month low of $11.50 and a 12 month high of $74.07. The company has a market capitalization of $596.92 million, a price-to-earnings ratio of -2.06 and a beta of 0.74.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of CTEV. State of Wyoming purchased a new position in shares of Claritev during the 4th quarter worth about $25,000. Public Employees Retirement System of Ohio bought a new position in Claritev in the 1st quarter valued at $38,000. Ameritas Investment Partners Inc. bought a new stake in shares of Claritev during the third quarter worth $42,000. Legal & General Group Plc purchased a new stake in shares of Claritev during the third quarter valued at $45,000. Finally, Los Angeles Capital Management LLC purchased a new position in Claritev in the 4th quarter worth about $45,000. 87.15% of the stock is owned by hedge funds and other institutional investors.

Claritev Company Profile

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.